PMC:7455510 / 89-1355 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":43,"end":51},"obj":"Disease"},{"id":"T4","span":{"begin":54,"end":67},"obj":"Disease"},{"id":"T5","span":{"begin":218,"end":226},"obj":"Disease"},{"id":"T6","span":{"begin":312,"end":320},"obj":"Disease"},{"id":"T7","span":{"begin":885,"end":893},"obj":"Disease"},{"id":"T8","span":{"begin":1103,"end":1111},"obj":"Disease"},{"id":"T9","span":{"begin":1114,"end":1123},"obj":"Disease"},{"id":"T10","span":{"begin":1210,"end":1218},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Limited information is available regarding SARS-CoV-2 infections in children with underlying diseases. A retrospective study of children less than 15 years old with primary or secondary immunosuppression infected with SARS-CoV-2 during March 2020 was performed. In this series, 8 immunocompromised patients with COVID-19 disease are reported, accounting for 15% of the positive cases detected in children in a reference hospital. The severity of the symptoms was mild-moderate in the majority with a predominance of febrile syndrome, with mild radiological involvement and in some cases with mild respiratory distress that required oxygen therapy. The rational and prudent management of these patients is discussed, evaluating possible treatments and options for hospitalization or outpatient follow-up.\nConclusion: In our experience, monitoring of children with immunosuppression and COVID-19 disease can be performed as outpatients if close monitoring is possible. Hospitalization should be assessed when high fever, radiological involvement, and/or respiratory distress are present.\nWhat is Known:\n• SARS-CoV-2 infection is usually mild in children.\nWhat is New:\n• Outcome of immunosuppressed children with COVID-19 is generally good, with a mild-moderate course."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":103,"end":104},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":408,"end":409},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":498,"end":499},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":1243,"end":1244},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Limited information is available regarding SARS-CoV-2 infections in children with underlying diseases. A retrospective study of children less than 15 years old with primary or secondary immunosuppression infected with SARS-CoV-2 during March 2020 was performed. In this series, 8 immunocompromised patients with COVID-19 disease are reported, accounting for 15% of the positive cases detected in children in a reference hospital. The severity of the symptoms was mild-moderate in the majority with a predominance of febrile syndrome, with mild radiological involvement and in some cases with mild respiratory distress that required oxygen therapy. The rational and prudent management of these patients is discussed, evaluating possible treatments and options for hospitalization or outpatient follow-up.\nConclusion: In our experience, monitoring of children with immunosuppression and COVID-19 disease can be performed as outpatients if close monitoring is possible. Hospitalization should be assessed when high fever, radiological involvement, and/or respiratory distress are present.\nWhat is Known:\n• SARS-CoV-2 infection is usually mild in children.\nWhat is New:\n• Outcome of immunosuppressed children with COVID-19 is generally good, with a mild-moderate course."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":632,"end":638},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"Limited information is available regarding SARS-CoV-2 infections in children with underlying diseases. A retrospective study of children less than 15 years old with primary or secondary immunosuppression infected with SARS-CoV-2 during March 2020 was performed. In this series, 8 immunocompromised patients with COVID-19 disease are reported, accounting for 15% of the positive cases detected in children in a reference hospital. The severity of the symptoms was mild-moderate in the majority with a predominance of febrile syndrome, with mild radiological involvement and in some cases with mild respiratory distress that required oxygen therapy. The rational and prudent management of these patients is discussed, evaluating possible treatments and options for hospitalization or outpatient follow-up.\nConclusion: In our experience, monitoring of children with immunosuppression and COVID-19 disease can be performed as outpatients if close monitoring is possible. Hospitalization should be assessed when high fever, radiological involvement, and/or respiratory distress are present.\nWhat is Known:\n• SARS-CoV-2 infection is usually mild in children.\nWhat is New:\n• Outcome of immunosuppressed children with COVID-19 is generally good, with a mild-moderate course."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":597,"end":617},"obj":"Phenotype"},{"id":"T2","span":{"begin":1012,"end":1017},"obj":"Phenotype"},{"id":"T3","span":{"begin":1052,"end":1072},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"Limited information is available regarding SARS-CoV-2 infections in children with underlying diseases. A retrospective study of children less than 15 years old with primary or secondary immunosuppression infected with SARS-CoV-2 during March 2020 was performed. In this series, 8 immunocompromised patients with COVID-19 disease are reported, accounting for 15% of the positive cases detected in children in a reference hospital. The severity of the symptoms was mild-moderate in the majority with a predominance of febrile syndrome, with mild radiological involvement and in some cases with mild respiratory distress that required oxygen therapy. The rational and prudent management of these patients is discussed, evaluating possible treatments and options for hospitalization or outpatient follow-up.\nConclusion: In our experience, monitoring of children with immunosuppression and COVID-19 disease can be performed as outpatients if close monitoring is possible. Hospitalization should be assessed when high fever, radiological involvement, and/or respiratory distress are present.\nWhat is Known:\n• SARS-CoV-2 infection is usually mild in children.\nWhat is New:\n• Outcome of immunosuppressed children with COVID-19 is generally good, with a mild-moderate course."}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":102},"obj":"Sentence"},{"id":"T4","span":{"begin":103,"end":261},"obj":"Sentence"},{"id":"T5","span":{"begin":262,"end":429},"obj":"Sentence"},{"id":"T6","span":{"begin":430,"end":647},"obj":"Sentence"},{"id":"T7","span":{"begin":648,"end":803},"obj":"Sentence"},{"id":"T8","span":{"begin":804,"end":815},"obj":"Sentence"},{"id":"T9","span":{"begin":816,"end":966},"obj":"Sentence"},{"id":"T10","span":{"begin":967,"end":1085},"obj":"Sentence"},{"id":"T11","span":{"begin":1086,"end":1100},"obj":"Sentence"},{"id":"T12","span":{"begin":1101,"end":1152},"obj":"Sentence"},{"id":"T13","span":{"begin":1153,"end":1165},"obj":"Sentence"},{"id":"T14","span":{"begin":1166,"end":1266},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Limited information is available regarding SARS-CoV-2 infections in children with underlying diseases. A retrospective study of children less than 15 years old with primary or secondary immunosuppression infected with SARS-CoV-2 during March 2020 was performed. In this series, 8 immunocompromised patients with COVID-19 disease are reported, accounting for 15% of the positive cases detected in children in a reference hospital. The severity of the symptoms was mild-moderate in the majority with a predominance of febrile syndrome, with mild radiological involvement and in some cases with mild respiratory distress that required oxygen therapy. The rational and prudent management of these patients is discussed, evaluating possible treatments and options for hospitalization or outpatient follow-up.\nConclusion: In our experience, monitoring of children with immunosuppression and COVID-19 disease can be performed as outpatients if close monitoring is possible. Hospitalization should be assessed when high fever, radiological involvement, and/or respiratory distress are present.\nWhat is Known:\n• SARS-CoV-2 infection is usually mild in children.\nWhat is New:\n• Outcome of immunosuppressed children with COVID-19 is generally good, with a mild-moderate course."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T3","span":{"begin":43,"end":53},"obj":"SP_7"},{"id":"T4","span":{"begin":186,"end":203},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T5","span":{"begin":218,"end":228},"obj":"SP_7"},{"id":"T6","span":{"begin":312,"end":320},"obj":"SP_7"},{"id":"T7","span":{"begin":597,"end":608},"obj":"UBERON:0001004"},{"id":"T8","span":{"begin":863,"end":880},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T9","span":{"begin":885,"end":893},"obj":"SP_7"},{"id":"T10","span":{"begin":1052,"end":1063},"obj":"UBERON:0001004"},{"id":"T11","span":{"begin":1103,"end":1113},"obj":"SP_7"},{"id":"T12","span":{"begin":1179,"end":1195},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T13","span":{"begin":1210,"end":1218},"obj":"SP_7"},{"id":"T94","span":{"begin":420,"end":431},"obj":"CL:0000542"},{"id":"T95","span":{"begin":1020,"end":1030},"obj":"DG_28"},{"id":"T72535","span":{"begin":43,"end":53},"obj":"SP_7"},{"id":"T88064","span":{"begin":186,"end":203},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T14587","span":{"begin":218,"end":228},"obj":"SP_7"},{"id":"T36054","span":{"begin":312,"end":320},"obj":"SP_7"},{"id":"T52381","span":{"begin":597,"end":608},"obj":"UBERON:0001004"},{"id":"T48927","span":{"begin":863,"end":880},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T25688","span":{"begin":885,"end":893},"obj":"SP_7"},{"id":"T36656","span":{"begin":1052,"end":1063},"obj":"UBERON:0001004"},{"id":"T55804","span":{"begin":1103,"end":1113},"obj":"SP_7"},{"id":"T65556","span":{"begin":1179,"end":1195},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T9892","span":{"begin":1210,"end":1218},"obj":"SP_7"}],"text":"Limited information is available regarding SARS-CoV-2 infections in children with underlying diseases. A retrospective study of children less than 15 years old with primary or secondary immunosuppression infected with SARS-CoV-2 during March 2020 was performed. In this series, 8 immunocompromised patients with COVID-19 disease are reported, accounting for 15% of the positive cases detected in children in a reference hospital. The severity of the symptoms was mild-moderate in the majority with a predominance of febrile syndrome, with mild radiological involvement and in some cases with mild respiratory distress that required oxygen therapy. The rational and prudent management of these patients is discussed, evaluating possible treatments and options for hospitalization or outpatient follow-up.\nConclusion: In our experience, monitoring of children with immunosuppression and COVID-19 disease can be performed as outpatients if close monitoring is possible. Hospitalization should be assessed when high fever, radiological involvement, and/or respiratory distress are present.\nWhat is Known:\n• SARS-CoV-2 infection is usually mild in children.\nWhat is New:\n• Outcome of immunosuppressed children with COVID-19 is generally good, with a mild-moderate course."}

{"project":"LitCovid-PubTator","denotations":[{"id":"17","span":{"begin":68,"end":76},"obj":"Species"},{"id":"18","span":{"begin":128,"end":136},"obj":"Species"},{"id":"19","span":{"begin":218,"end":228},"obj":"Species"},{"id":"20","span":{"begin":298,"end":306},"obj":"Species"},{"id":"21","span":{"begin":396,"end":404},"obj":"Species"},{"id":"22","span":{"begin":693,"end":701},"obj":"Species"},{"id":"23","span":{"begin":782,"end":792},"obj":"Species"},{"id":"24","span":{"begin":632,"end":638},"obj":"Chemical"},{"id":"25","span":{"begin":43,"end":64},"obj":"Disease"},{"id":"26","span":{"begin":204,"end":212},"obj":"Disease"},{"id":"27","span":{"begin":312,"end":320},"obj":"Disease"},{"id":"28","span":{"begin":516,"end":532},"obj":"Disease"},{"id":"29","span":{"begin":597,"end":617},"obj":"Disease"},{"id":"32","span":{"begin":1143,"end":1151},"obj":"Species"},{"id":"33","span":{"begin":1108,"end":1123},"obj":"Disease"},{"id":"36","span":{"begin":1196,"end":1204},"obj":"Species"},{"id":"37","span":{"begin":1210,"end":1218},"obj":"Disease"},{"id":"42","span":{"begin":849,"end":857},"obj":"Species"},{"id":"43","span":{"begin":885,"end":893},"obj":"Disease"},{"id":"44","span":{"begin":1012,"end":1017},"obj":"Disease"},{"id":"45","span":{"begin":1052,"end":1072},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Tax:9606"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Tax:9606"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:2697049"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:9606"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Tax:9606"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:9606"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"MESH:D010100"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"MESH:C000657245"},{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"MESH:D007239"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:C000657245"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:D000071072"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:D012128"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:9606"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000657245"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"Tax:9606"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:C000657245"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Tax:9606"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:C000657245"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D005334"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Limited information is available regarding SARS-CoV-2 infections in children with underlying diseases. A retrospective study of children less than 15 years old with primary or secondary immunosuppression infected with SARS-CoV-2 during March 2020 was performed. In this series, 8 immunocompromised patients with COVID-19 disease are reported, accounting for 15% of the positive cases detected in children in a reference hospital. The severity of the symptoms was mild-moderate in the majority with a predominance of febrile syndrome, with mild radiological involvement and in some cases with mild respiratory distress that required oxygen therapy. The rational and prudent management of these patients is discussed, evaluating possible treatments and options for hospitalization or outpatient follow-up.\nConclusion: In our experience, monitoring of children with immunosuppression and COVID-19 disease can be performed as outpatients if close monitoring is possible. Hospitalization should be assessed when high fever, radiological involvement, and/or respiratory distress are present.\nWhat is Known:\n• SARS-CoV-2 infection is usually mild in children.\nWhat is New:\n• Outcome of immunosuppressed children with COVID-19 is generally good, with a mild-moderate course."}